Trillium Therapeutics to Report Preclinical Data on Its STING Program at the SITC 34th Annual Meeting

NEXT STORY
Albireo Reports Third Quarter 2019 Financial Results and Provides Business Update
PREV STORY
Madrigal Pharmaceuticals Reports 2019 Third Quarter Financial Results and Highlights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Allergan and Editas Medicine Initiate the Brilliance Phase 1/2 Clinical Trial of AGN-151587 (EDIT-101) for the Treatment of LCA10

author_avatar
NASDAQ Market News

Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019

author_avatar
NASDAQ Market News

Global PoC Molecular Diagnostic Market is estimated to be US$ 6.7 Billion by 2029 with a CAGR of 14.8% during the Forecast Period – PMI

author_avatar
NASDAQ Market News